Benzinga | Sep 2, 2020 11:19AM EDT

BMO Capital Maintains Market Perform on Amedisys, Raises Price Target to $270

BMO Capital analyst Matt Borsch maintains Amedisys (NASDAQ:AMED) with a Market Perform and raises the price target from $250 to $270.